Marka dadka badankood ay ka hadlaan daaweynta HIV , waxay guud ahaan u maleeyaan nooc gaar ah oo ah daroogada. Waxay u malaynayaan in daaweyntu ay ka saari doonto dhammaan fayruska jirka - daaweynta ciribtirka. Si kastaba ha ahaatee, dhakhaatiir badan oo raadinaya daaweyn HIV ayaa dhab ahaantii raadinaya nooc ka duwan daaweynta. Daaweyn ficil ah oo HIV-ga ah lagama-maarmaan ah kuma koobnaayo in laga tirtiro dhammaan fayruska jirka.
Taa baddalkeeda, himilada daaweynta ficil ahaaneed waxay noqon doontaa in laga takhaluso HIV-da oo dhan oo laga saaro saameyn taban. Si kale haddii loo dhigo, dadka jirkoodu si fiican u bogsoon lahaa weligood kuma dhicin AIDS ama calaamadaha kale ee cudurka HIV, sida gabowgii hore .
Farqiga u dhaxeeya Kufsi Sheegista iyo Daaweynta Ficilka
Farqiga ugu weyn ee u dhexeeya ciribtirka ciribtirka iyo daaweynta ficilka waa mid la taaban karo. Markaad raadinayso daaweyn farsamo, saynisyahadu maaha inay ka walwalaan haddii ay si guul leh u nadiifiyeen bakhaarka fayrasku. (Kaydka fayrusku waa waa maxay saynisyahannada oo ku magacaaba nuqullo fayraska ah oo si qarsoodi ah u qarinaya meelo kala duwan oo jirka ah Fayraskan qarsooni ma awoodi karo inuu la dagaallamo ama la daweeyo illaa iyo haddii aysan jirin wax sabab u ah inuu dhaqdhaqaaqo iyo inuu bilaabo inuu soo saaro.) Halkii, si loo tijaabiyo qof si daaweyn ficil ah, dhakhaatiirtu kaliya waa inay sameeyaan qaar ka mid ah heerarka fayruska ee dhiigooda aan la ogaan karin.
Waa inay sidoo kale hubiyaan in nidaamkooda difaaca uu u shaqeynayo sidoo kale waxay yeelan laheyd haddii aan la qaadin HIV.
Ilaa xad, arrintani hadda waa la dhammeeyaa-iyadoo la adeegsanayo isticmaalka dheeraadka ah ee daaweynta daaweynta antiretroviral (CART). Si kastaba ha ahaatee, rajada guud waa in daaweyn dhab ah oo farsamo ah ay awoodi karto in ay gaaraan hadafyadaas iyada oo aan bukaanno u baahan in ay sii joogteeyaan xayiraad weligeed ah.
Inkasta oo daroogooyinka loo isticmaalo qayb-yaraansho ay si aad ah u hagaajiyeen nolosha dadka qaba HIV, waxay sidoo kale yeelan karaan saameyno muhiim ah. Sidaa daraadeed, daaweynta farsamda ee habboon waxay bukaanku ku qaadi karaan HIV-ga ilaa meeshii ay daroogooyinka aan loo baahneyn si ay u ilaaliyaan infakshooda.
Wadada loo maro daaweynta HIV-ga
Daaweyn waxtar leh ayaa laga yaabaa inay suurtagal tahay. Wararkii ugu dambeeyay ee daaweyntu waxay bilaabeen inay xajiyaan xilliga xagaaga 2012, markii ay jiraan labo khadad oo cilmi baaris ah oo muujiyay in HIV-ga la xakameyn karo kooxo bukaan ah. Daraasada koowaad ee daraasadda, oo heshay faafinta ugu badan, waxay ku lug leedahay bukaanka Berlin. Bukaanka Berlin waa nin oo infekshanka HIV u muuqday in la cirib tiray kadib markii la siiyey xubin kaabis ah lafo-beelka laf-dhabarka CCR5. Cilmi-baadhis lagu soo bandhigay Shirweynihii 19aad ee Cudurka Caalamiga ah ee Caalamiga ah ayaa lagu ogaaday laba qof oo lafo-beelka lafaha oo kale ah kuwaas oo cudur-sidaha HIV-ga u muuqday in la xakameeyay xubinta taranka. Si kastaba ha noqotee, noocan daaweynta ma noqon doonto mid ikhtiyaari ah dadka badidiisa qaba HIV. Waa wax aad halis u ah. Waxay u badan tahay in mar kasta loo isticmaalo bukaanada qaba HIV-ga oo u baahan in lafo-beelka lafo-beelka ah loo sameeyo sababo kale.
Farax aad u xiiso badan ayaa ah xaqiiqda ah in kooxo badan oo ka mid ah saynisyahannadu ay ku guuleysteen inay daaweeyaan dadka si dhakhso ah markii ay qaadeen cudurka HIV. Waxa ay u muuqataa in daweyntii hore ay awood u leedahay inay ka hortagto horumarinta kaydka ballaaran ee fayraska. Daaweynta xilli hore sida tan waxay u muuqataa in ay garaacdo fayras hoose oo hooseeya oo ku filan in nidaamka difaaca bukaanka uu xakameyn karo infekshanka haraaga iyada oo aan la isticmaalin daawooyinka antiretroviral . Natiijooyinka weli waa hordhac. Hase yeeshee, tani waa nooc ka mid ah daaweynta ficil ahaaneed ee laga yaabo, in aragtida, lagu fulin karo miisaan ballaadhan. Taas waxay sheegtay, in ay run ahaantii faa'iido leedahay haddii baaritaanka HIV-ga si weyn loo hagaajiyo.
Haddii aan la tallaalin horay, looma daaweyn karo goor hore. Waqtigaan hadda, dad aad u tiro badan ayaa cudurka qaba sanado badan ka hor inta aanay ogaanin inay HIV-ga qabaan.
Ilaha:
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T. (2011) "Caddaynta daaweynta cudurka HIV-ga ee CCR5Δ32 / Δ32 transplantation cell." Dhiiga. 117 (10): 2791-9.
Bacchus, C., Hocqueloux, L., Avettand-Fenoe, V., Saez-Cirion, A., Melard, A., Qaadasho, B., Samril, A., Blanc, C., Autran, B., Rouzioux , C., VISCONTI & ALT ANRS kooxaha waxbarashada. "Qeybinta kaydka HIV-ga ee bukaanada si isdaba joog ah loo ilaaliyo caabuqa HIV-ga ka dib joojinta daaweynta." AIDS 2012 Abstract THAA0103
> Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Keigh SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR. Cadaadiska muddada dheer ee dhiigga dillaacaya nooca HIV-ga 1 kaydka ka dib marka la yareeyo qaboojinta qaboojinta qaboojinta unugyada unugyada unugyada unugyada unugyada unugyada qanjirada 'allogeneic stem cell'. Jirada Caabuqa. 2013 Jun 1; 207 (11): 1694-702. doi: 10.1093 / infdis / jit086.
> Poveda E, Crespo M. Waa Goorma Daaweeynta Antiretroviral Early Early for the Removal of HIV? AIDS Rev. 2017 Apr - Jun; 19 (2): 113-114.
> Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, Potard V, Versmisse P, Melard A, Prazuck T, Qalabka B, Guergnon J, Viard JP, Boufassa F, Lambotte O, Goujard C, Meyer L, Costagliola D, Venet A, Pancino G, Autran B, Rouzioux C; Kooxda Daraasada ANRS VISCONTI. Daaweynta post-daweynta HIV-1 oo leh daaweyn waqti dheer oo dheellitiran kadib markii la joojiyey joojinta daaweynta antiretroviral ee horay loo bilaabay ANRS VISCONTI. Qodobbada Wadnaha. 2013 Mar; 9 (3): e1003211. doi: 10.1371 / journal.ppat.1003211.